Advertisement

Haemostasis pp 207-225 | Cite as

Platelet Morphology Analysis

  • Véronique Latger-Cannard
  • Odile Fenneteau
  • Sylvain Salignac
  • Thomas Pierre Lecompte
  • Nicole Schlegel
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 992)

Abstract

Platelets are very small blood cells (1.5–3 μm), which play a major role in primary haemostasis and in coagulation mechanisms. Platelet characterization requires their counting (see  Chapter 15) associated with accurate morphology analysis. We describe the major steps in order to correctly obtain stained blood films, which can be analyzed by optical microscope. Platelet morphology abnormalities are found in acquired malignant hematological diseases such myeloproliferative or myelodysplastic syndromes and acute megakaryoblastic leukemia. A careful analysis of the platelet size and morphology, by detecting either normal platelets with or without excessive anisocytosis, microplatelets, or large/giant platelets, will contribute to inherited thrombocytopenia diagnosis and gather substantial data when looking for an acquired platelet disorders.

Key words

Platelets Morphology Thrombocytopenia Platelet disorders Inherited thrombocytopenia 

References

  1. 1.
    Levine RF, Olson TA, Shoff PK, Miller MK, Weisman LE (1996) Mature micromegakaryocytes: an unusual developmental pattern in term infants. Br J Haematol 94: 391–399PubMedCrossRefGoogle Scholar
  2. 2.
    Brière J (1995) Thrombocytémie essentielle. Encycl Med Chir Hématologie 13-020-B-05, p 10.Google Scholar
  3. 3.
    Flandrin G, Lessard M (1991) Syndromes myélodysplasiques. Encycl Med Chir, (Paris-France), Hématologie, 13012 A10, p 8.Google Scholar
  4. 4.
    Benett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al (1985) Criteria for the diagnosis of acute leukaemia of megakaryocyte lineage. A report of the French-American-British Cooperative Group, Ann Intern Med. 103:460–462.Google Scholar
  5. 5.
    Latger-Cannard V, Sommelet D, Guerci B, Tréchot P, Lecompte T (2001) Platelet gigantism associated with cholestyramine therapy. Arch Intern Med 161:2619–2620PubMedCrossRefGoogle Scholar
  6. 6.
    Stöckler S, Molzer B, Plecko B, Zen W, Muntean W, Söling U et al (1993) Giant platelets in erucic acid therapy for adrenoleukodystrophy. Lancet 341:1414–1415PubMedCrossRefGoogle Scholar
  7. 7.
    Balduini CL, Cattaneo M, Fabris F, Gresele P, Iolascon A, Pulcinelli FM, on behalf of the Italian “Gruppo di Studio delle Piastrine” et al (2003) Inherited thrombocytopenias: a proposed diagnostic algorithm from the Italian Gruppo di Studio delle Piastrine. Platelets 88:582–592Google Scholar
  8. 8.
    Geddis AE, Kaushansky K (2004) Inherited thrombocytopenias: towards a molecular understanding of disorders of platelet production. Curr Opin Pediatr 16:15–24PubMedCrossRefGoogle Scholar
  9. 9.
    Nurden AT (2005) Qualitative disorders of platelets and megakaryocytes. J Thromb Haemost 3:1773–1782PubMedCrossRefGoogle Scholar
  10. 10.
    Nurden P, Nurden AT (2008) Congenital disorders associated with platelet dysfunctions. Thromb Haemost 99:253–263PubMedGoogle Scholar
  11. 11.
    Latger-Cannard V, Salignac S, Salmon A, Mansuy L, de Maistre E, Botte C et al (2005) Thrombocytopenia: clinicobiologic validation and classification. Ann Biol Clin 63:1–12Google Scholar
  12. 12.
    Drachman JG, Jarvik GP, Mehaffey MG (2000) Autosomal dominant thrombocytopenia: incomplete megakaryocyte differentiation and linkage to chromosome 10. Blood 96:118–125PubMedGoogle Scholar
  13. 13.
    Pipucci T, Savoia A, Perrotta S, Pujol-Moix N, Noris P, Castegnaro G et al (2011) Mutations in the 5′-UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2. Am J Hum Genet 88:115–120CrossRefGoogle Scholar
  14. 14.
    King S, Germeshausen M, Strauss G, Welte K, Ballmaier M (2005) Congenital amegakaryocytic thrombocytopenia: a retrospective clinical analysis of 20 patients. Br J Haematol 131:636–644PubMedCrossRefGoogle Scholar
  15. 15.
    Greenhalgh K, Howell R, Bottani A, Ancliff P, Brunner H, Verschuuren-Bemelmans C et al (2002) Thrombocytopenia-absent radius syndrome: a clinical genetic study. J Med Genet 39:876–881PubMedCrossRefGoogle Scholar
  16. 16.
    Béri-Dexheimer M, Latger-Cannard V, Philippe C, Bonnet C, Chambon P et al (2008) Clinical phenotype of germline RUNX1 haploinsufficiency: from point mutations to large genomic deletions. Eur J Hum Genet 16:1014–1018PubMedCrossRefGoogle Scholar
  17. 17.
    Latger-Cannard V, Proust A, Devignes J, Salignac S, Bensoussan D, Salmon A et al (2008) A Wiskott-Aldrich syndrome revealed by a careful morphological examination of the platelets in a child. Hématologie 14:387–391Google Scholar
  18. 18.
    Latger-Cannard V, Bensoussan D, Grégoire MJ, Marçon F, Cloez JL, Leheup B et al (2004) Frequency of thrombocytopenia and large platelets correlate neither with conotruncal cardiac anomalies nor immunologic features in chromosome 22q11.2 deletion syndrome. Eur J Pediatrics 163:327–328CrossRefGoogle Scholar
  19. 19.
    Liang HP, Morel-Kopp MC, Curtin J, Wilson M, Hewson J, Chen W et al (2007) Heterozygous loss of platelet glycoprotein (GP) Ib-V-IX variably affects platelet function in velocardiofacial syndrome (VCFS) patients. Thromb Haemost 98:1298–1308PubMedGoogle Scholar
  20. 20.
    Najean Y, Lecompte T (1990) Genetic thrombocytopenia with autosomal dominant transmission: a review of 54 cases. Br J Haematol 74:203–208PubMedCrossRefGoogle Scholar
  21. 21.
    Savoia A, Balduini CL, Savino M, Noris P, Del Vecchio M, Perrotta S et al (2001) Autosomal dominant macrothrombocytopenia in Italy is most frequently a type of heterozygous Bernard-Soulier syndrome. Blood 97:1330–1335PubMedCrossRefGoogle Scholar
  22. 22.
    Ciovacco W, Raskind W, Kacena M (2008) Human phenotypes associated with GATA-1 mutations. Genet 427:1–6Google Scholar
  23. 23.
    Kunishima S, Yoshinari M, Nishio H, Ida K, Miura T, Matsushita T et al (2007) Haematological characteristics of MYH9 disorders due to MYH9 R702 mutations. Eur J Haematol 78:220–226PubMedCrossRefGoogle Scholar
  24. 24.
    Kunishima S, Matsushita T, Kojima T, Sako M, Kimura F, Jo E-K et al (2003) Immunofluorescence analysis of neutrophil Non Muscle Myosin Heavy Chain-A in MYH9 disorders: association of subcellular localization with MYH9 mutations. Lab Invest 83:115–122PubMedGoogle Scholar
  25. 25.
    Pecci A, Panza E, Pujol-Moix N, Klersy C, Di Bari F, Bozzi V et al (2008) Position of non-muscle myosin heavy chain IIA mutations predicts the natural history of MYH9-related disease. Hum Mutat 29:409–417PubMedCrossRefGoogle Scholar
  26. 26.
    Pecci A, Panza E, De Rocco D, Pujol-Moix N, Girotto G, Podda L et al (2009) MYH9 related disease: four novel mutations of the tail domain of myosin-9 correlating with a mild clinical phenotype. Eur J Haematol 84:291–297PubMedCrossRefGoogle Scholar
  27. 27.
    Stewart GW, Makris M (2008) Mediterranean macrothrombocytopenia and phytosterolaemia/sitosterolaemia. Haematologica 93:e29PubMedCrossRefGoogle Scholar
  28. 28.
    Rees DC, Iolascon A, Carella M, O’marcaigh AS, Kendra JR, Jowitt SN et al (2005) Stomatocytic haemolysis and macrothrombocytopenia (Mediterranean stomatocytosis/macrothrombocytopenia) is the haematological presentation of phytosterolaemia. Br J Haematol 130:297–309PubMedCrossRefGoogle Scholar
  29. 29.
    Nurden P, Debili N, Vainchenker W, Bobe R, Bredoux R, Corvazier E et al (2006) Impaired megakaryocytopoiesis in type 2B Willebrand disease with severe thrombocytopenia. Blood 108:2587–2595PubMedCrossRefGoogle Scholar
  30. 30.
    Thompson AA, Nguyen LT (2000) Amegakaryocytic thrombocytopenia and radio-ulnar synostosis are associated with HOXA11 mutation. Nat Genet 26:397–398PubMedCrossRefGoogle Scholar
  31. 31.
    Nurden AT, Nurden P (2007) The gray platelet syndrome: clinical spectrum of the disease. Blood Rev 21:21–36PubMedCrossRefGoogle Scholar
  32. 32.
    Gunay-Agun M, Falik-Zaccai TC, Vilboux T, Zivony-Elboum Y, Gumruk F, Cetin M et al (2011) NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet alpha-granules. Nat Genet 43:732–734CrossRefGoogle Scholar
  33. 33.
    Fabbro S, Hinckley J, Li L, Schwertz H, Christensen H, Rowley JW et al (2011) Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome. Nat Genet 43:738–740PubMedCrossRefGoogle Scholar
  34. 34.
    Albers CA, Cvejic A, Favier R, Bouwmans EE, Alessi MC, Bertone P et al (2011) Exome sequencing identifies NBEAL2 gene as the causative gene for gray platelet syndrome. Nat Genet 43:735–737PubMedCrossRefGoogle Scholar
  35. 35.
    Jacobsen P, Hauge M, Henningsen K (1973) An (11;21) translocation in four generation with chromosome 11 abnormalities in the off-spring. A clinical, cytogenetical and gene marker study. Hum Hered 23:568–585PubMedCrossRefGoogle Scholar
  36. 36.
    Favier R, Jondeau K, Boutard P, Grossfeld P, Reinert P, Jones C et al (2003) Paris-Trousseau syndrome: clinical, hematological, molecular data of ten new cases. Thromb Haemost 90:893–897PubMedGoogle Scholar
  37. 37.
    Breton-Gorius J, Favier R, Guichard J, Cherif D, Berger R, Debili N et al (1995) New ­congenital dysmegakaryopoietic thrombocytopenia (Paris-Trousseau) associated with giant platelet alpha-granules and chromosome 11 deletion at 11q23. Blood 85:1805–114PubMedGoogle Scholar
  38. 38.
    Valduga M, Latger-Cannard V, Philippe C, Romana S, Miton A, Droulle P et al (2007) Prenatal diagnosis of mosaïcism for 11q terminal deletion. Eur J Med Genet 50:475–481PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press 2013

Authors and Affiliations

  • Véronique Latger-Cannard
    • 1
  • Odile Fenneteau
    • 2
  • Sylvain Salignac
    • 1
  • Thomas Pierre Lecompte
    • 3
  • Nicole Schlegel
    • 2
  1. 1.Hematology Department and Grand East Competence Center on Inherited Platelet DisordersCHU NancyNancyFrance
  2. 2.Biological Hematology DepartmentNational French Reference Center on Inherited Platelet Disorders (CRPP), Robert Debré Hospital, AP-HP and Paris 7 Denis Diderot UniversityParisFrance
  3. 3.Département des Spécialités de Médecine, Service d’HématologieHôpitaux Universitaires de Genève (HUG)GenevaSwitzerland

Personalised recommendations